Literature DB >> 16731860

HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months.

Emma L Edghill1, Rachel J Dix, Sarah E Flanagan, Polly J Bingley, Andrew T Hattersley, Sian Ellard, Kathleen M Gillespie.   

Abstract

Children with permanent diabetes are usually assumed to have type 1 diabetes. It has recently been shown that there are genetic subgroups of diabetes that are often diagnosed during the neonatal period but may present later. A recent Italian study proposed that type 1 diabetes is rare before 6 months of age. We aimed to examine genetic susceptibility to type 1 diabetes in patients diagnosed with diabetes before the age of 2 years. We analyzed HLA class II genotypes, markers of autoimmune diabetes, in 187 children with permanent diabetes diagnosed at <2 years of age. Of the 79 subjects diagnosed at <6 months of age, 41% (95% CI 0.30-0.51) had type 1 diabetes-associated high-risk genotypes, a proportion similar to that in healthy population control subjects (44%, P=0.56). This group included 32 patients with mutations in the KCNJ11 gene, which encodes Kir6.2 (44% high-risk HLA class II genotypes), and 47 in whom the etiology of diabetes was unknown (38% high-risk HLA class II genotypes). Of 108 patients diagnosed between 6 and 24 months of age, 93% (0.86-0.99) had high-risk HLA class II genotypes compared with 44% of the population control subjects (P<0.0001). We conclude that infants diagnosed with diabetes before 6 months of age are unlikely to have autoimmune type 1 diabetes and are most likely to have a monogenic etiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731860     DOI: 10.2337/db06-0094

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  33 in total

Review 1.  Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.

Authors:  Emma L Edghill; Sarah E Flanagan; Sian Ellard
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

2.  Detection of KCNJ11 gene mutations in a family with neonatal diabetes mellitus: implications for therapeutic management of family members with long-standing disease.

Authors:  Farzaneh Abbasi; Sadaf Saba; Azadeh Ebrahim-Habibi; Forough A Sayahpour; Parvin Amiri; Bagher Larijani; Mahsa M Amoli
Journal:  Mol Diagn Ther       Date:  2012-04-01       Impact factor: 4.074

Review 3.  Neonatal diabetes mellitus: a model for personalized medicine.

Authors:  Siri Atma W Greeley; Susan E Tucker; Rochelle N Naylor; Graeme I Bell; Louis H Philipson
Journal:  Trends Endocrinol Metab       Date:  2010-04-29       Impact factor: 12.015

4.  Diagnosis and treatment of neonatal diabetes: a United States experience.

Authors:  Julie Støy; Siri Atma W Greeley; Veronica P Paz; Honggang Ye; Ashley N Pastore; Kinga B Skowron; Rebecca B Lipton; Fran R Cogen; Graeme I Bell; Louis H Philipson
Journal:  Pediatr Diabetes       Date:  2008-07-25       Impact factor: 4.866

5.  Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families.

Authors:  Oscar Rubio-Cabezas; Ann-Marie Patch; Jayne A L Minton; Sarah E Flanagan; Emma L Edghill; Khalid Hussain; Amina Balafrej; Asma Deeb; Charles R Buchanan; Ian G Jefferson; Angham Mutair; Andrew T Hattersley; Sian Ellard
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

Review 6.  Wolcott-Rallison syndrome.

Authors:  Cécile Julier; Marc Nicolino
Journal:  Orphanet J Rare Dis       Date:  2010-11-04       Impact factor: 4.123

7.  Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities.

Authors:  Oscar Rubio-Cabezas; Jayne A L Minton; Iren Kantor; Denise Williams; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes       Date:  2010-06-23       Impact factor: 9.461

8.  Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes.

Authors:  Oscar Rubio-Cabezas; Jayne A L Minton; Richard Caswell; Julian P Shield; Dorothee Deiss; Zdenek Sumnik; Amely Cayssials; Mathias Herr; Anja Loew; Vaughan Lewis; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2008-10-17       Impact factor: 17.152

9.  A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency.

Authors:  Marc Nicolino; Kathryn C Claiborn; Valérie Senée; Anne Boland; Doris A Stoffers; Cécile Julier
Journal:  Diabetes       Date:  2009-12-15       Impact factor: 9.461

10.  Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births.

Authors:  A S Slingerland; B M Shields; S E Flanagan; G J Bruining; K Noordam; A Gach; W Mlynarski; M T Malecki; A T Hattersley; S Ellard
Journal:  Diabetologia       Date:  2009-06-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.